Full dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China

INTRODUCTION: To investigate the effect of dose maintenance, reduction, or discontinuation of the etanercept biosimilar Yisaipu (YSP) on early axial spondyloarthritis (axSpA) patients in remission with YSP 50 mg once weekly (QW). MATERIAL AND METHODS: Patients were enrolled in three groups: full dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kun-Peng, Jin, Jing-Yu, Yang, Jin-Shui, Li, Yan, Zhao, Wei, Luo, Gui, Zhu, Jian, Zhang, Jiang-Lin, Huang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524190/
https://www.ncbi.nlm.nih.gov/pubmed/31110537
http://dx.doi.org/10.5114/aoms.2018.76141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524190/
https://www.ncbi.nlm.nih.gov/pubmed/31110537
http://dx.doi.org/10.5114/aoms.2018.76141

Ejemplares similares